These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
935 related articles for article (PubMed ID: 15503312)
21. The spectrum of spitzoid tumours: A clinical study. Hafiji J; Rytina E; Burrows NP Australas J Dermatol; 2012 Aug; 53(3):211-5. PubMed ID: 22671697 [TBL] [Abstract][Full Text] [Related]
22. Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report. Vachtenheim J; Kodet R; Fischer O; Kolek V; Strizova Z; Ozaniak A; Simonek J; Stolz A; Pozniak J; Kolarik J; Svorcova M; Vachtenheim J; Lischke R Diagn Pathol; 2020 Oct; 15(1):132. PubMed ID: 33100226 [TBL] [Abstract][Full Text] [Related]
23. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma. Mason A; Wititsuwannakul J; Klump VR; Lott J; Lazova R J Cutan Pathol; 2012 Dec; 39(12):1062-74. PubMed ID: 23005921 [TBL] [Abstract][Full Text] [Related]
24. S100A6 protein expression is different in Spitz nevi and melanomas. Ribé A; McNutt NS Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257 [TBL] [Abstract][Full Text] [Related]
25. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, 'Spitzoid melanoma' and risk assessment. Barnhill RL Mod Pathol; 2006 Feb; 19 Suppl 2():S21-33. PubMed ID: 16446713 [TBL] [Abstract][Full Text] [Related]
26. Spitz nevus and atypical spitzoid neoplasm. Miteva M; Lazova R Semin Cutan Med Surg; 2010 Sep; 29(3):165-73. PubMed ID: 21051010 [TBL] [Abstract][Full Text] [Related]
27. The T1796A mutation of the BRAF gene is absent in Spitz nevi. Palmedo G; Hantschke M; Rütten A; Mentzel T; Hügel H; Flaig MJ; Yazdi AS; Sander CA; Kutzner H J Cutan Pathol; 2004 Mar; 31(3):266-70. PubMed ID: 14984580 [TBL] [Abstract][Full Text] [Related]
30. Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors. Zaremba A; Jansen P; Murali R; Mayakonda A; Riedel A; Philip M; Rose C; Schaller J; Müller H; Kutzner H; Möller I; Stadtler N; Kretz J; Sucker A; Bankfalvi A; Livingstone E; Zimmer L; Horn S; Paschen A; Plass C; Schadendorf D; Hadaschik E; Lutsik P; Griewank K Int J Cancer; 2022 Nov; 151(9):1542-1554. PubMed ID: 35737508 [TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). Murali R; Sharma RN; Thompson JF; Stretch JR; Lee CS; McCarthy SW; Scolyer RA Ann Surg Oncol; 2008 Jan; 15(1):302-9. PubMed ID: 18000712 [TBL] [Abstract][Full Text] [Related]
32. Spitz nevi and Spitzoid melanomas: exome sequencing and comparison with conventional melanocytic nevi and melanomas. Lazova R; Pornputtapong N; Halaban R; Bosenberg M; Bai Y; Chai H; Krauthammer M Mod Pathol; 2017 May; 30(5):640-649. PubMed ID: 28186096 [TBL] [Abstract][Full Text] [Related]
33. The superficial atypical Spitz tumor and malignant melanoma of superficial spreading type arising in association with the superficial atypical Spitz tumor: A distinct form of dysplastic Spitzoid nevomelanocytic proliferation. Magro CM; Yaniv S; Mihm MC J Am Acad Dermatol; 2009 May; 60(5):814-23. PubMed ID: 19389523 [TBL] [Abstract][Full Text] [Related]
34. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features. Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786 [TBL] [Abstract][Full Text] [Related]
35. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Nasr MR; El-Zammar O Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113 [TBL] [Abstract][Full Text] [Related]